Therapeutic adherence in hypertension: Current evidence and expert opinion from India

Hypertension (HTN) is a globally prevalent non-communicable disease contributing significantly to cardiovascular (CV) morbidity and mortality. In achieving control of HTN, therapeutic adherence plays a crucial role. Studies from India identify varying rates of adherence to antihypertensive medicatio...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jamshed J. Dalal, Prafulla Kerkar, Santanu Guha, Arup Dasbiswas, J.P.S. Sawhney, Sivakadaksham Natarajan, Srinivasa Rao Maddury, A. Sreenivas Kumar, Nishith Chandra, Gulla Suryaprakash, Joy M. Thomas, N.I. Juvale, Sunil Sathe, Aziz Khan, Sandeep Bansal, Viveka Kumar, Rajshekhar Reddi
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Hypertension Adherence Cardiovascular disease Antihypertensives medications Blood pressure Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/68c1549d50c9417eabbedcbf7b1ddafd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:68c1549d50c9417eabbedcbf7b1ddafd
record_format	dspace
spelling	oai:doaj.org-article:68c1549d50c9417eabbedcbf7b1ddafd2021-12-02T04:57:58ZTherapeutic adherence in hypertension: Current evidence and expert opinion from India0019-483210.1016/j.ihj.2021.09.003https://doaj.org/article/68c1549d50c9417eabbedcbf7b1ddafd2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0019483221001905https://doaj.org/toc/0019-4832Hypertension (HTN) is a globally prevalent non-communicable disease contributing significantly to cardiovascular (CV) morbidity and mortality. In achieving control of HTN, therapeutic adherence plays a crucial role. Studies from India identify varying rates of adherence to antihypertensive medications. Multiple factors determine treatment adherence in HTN. In India, factors such as lower socioeconomic status, health literacy, asymptomatic nature of disease, forgetfulness, cost of medications, and duration of HTN determine the adherence. An excellent physician-patient relationship incorporating adequate counseling along with the use of other methods can identify poor adherence. Improving adherence necessitates incorporating a multipronged approach with strategies directed at physicians, patients, and health systems. With innovation in therapeutics, the pharmaceutical sector can contribute significantly to improve adherence. Furthermore, increasing adherence to lifestyle interventions can help achieve better HTN control and improve CV outcomes. In the Indian context, more emphasis is necessary on patient education, enhanced physician-patient relationship and communication, increased access to health care, and affordability in improving therapeutic adherence in HTN.Jamshed J. DalalPrafulla KerkarSantanu GuhaArup DasbiswasJ.P.S. SawhneySivakadaksham NatarajanSrinivasa Rao MadduryA. Sreenivas KumarNishith ChandraGulla SuryaprakashJoy M. ThomasN.I. JuvaleSunil SatheAziz KhanSandeep BansalViveka KumarRajshekhar ReddiElsevierarticleHypertensionAdherenceCardiovascular diseaseAntihypertensives medicationsBlood pressureSurgeryRD1-811Diseases of the circulatory (Cardiovascular) systemRC666-701ENIndian Heart Journal, Vol 73, Iss 6, Pp 667-673 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Hypertension Adherence Cardiovascular disease Antihypertensives medications Blood pressure Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Hypertension Adherence Cardiovascular disease Antihypertensives medications Blood pressure Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701 Jamshed J. Dalal Prafulla Kerkar Santanu Guha Arup Dasbiswas J.P.S. Sawhney Sivakadaksham Natarajan Srinivasa Rao Maddury A. Sreenivas Kumar Nishith Chandra Gulla Suryaprakash Joy M. Thomas N.I. Juvale Sunil Sathe Aziz Khan Sandeep Bansal Viveka Kumar Rajshekhar Reddi Therapeutic adherence in hypertension: Current evidence and expert opinion from India
description	Hypertension (HTN) is a globally prevalent non-communicable disease contributing significantly to cardiovascular (CV) morbidity and mortality. In achieving control of HTN, therapeutic adherence plays a crucial role. Studies from India identify varying rates of adherence to antihypertensive medications. Multiple factors determine treatment adherence in HTN. In India, factors such as lower socioeconomic status, health literacy, asymptomatic nature of disease, forgetfulness, cost of medications, and duration of HTN determine the adherence. An excellent physician-patient relationship incorporating adequate counseling along with the use of other methods can identify poor adherence. Improving adherence necessitates incorporating a multipronged approach with strategies directed at physicians, patients, and health systems. With innovation in therapeutics, the pharmaceutical sector can contribute significantly to improve adherence. Furthermore, increasing adherence to lifestyle interventions can help achieve better HTN control and improve CV outcomes. In the Indian context, more emphasis is necessary on patient education, enhanced physician-patient relationship and communication, increased access to health care, and affordability in improving therapeutic adherence in HTN.
format	article
author	Jamshed J. Dalal Prafulla Kerkar Santanu Guha Arup Dasbiswas J.P.S. Sawhney Sivakadaksham Natarajan Srinivasa Rao Maddury A. Sreenivas Kumar Nishith Chandra Gulla Suryaprakash Joy M. Thomas N.I. Juvale Sunil Sathe Aziz Khan Sandeep Bansal Viveka Kumar Rajshekhar Reddi
author_facet	Jamshed J. Dalal Prafulla Kerkar Santanu Guha Arup Dasbiswas J.P.S. Sawhney Sivakadaksham Natarajan Srinivasa Rao Maddury A. Sreenivas Kumar Nishith Chandra Gulla Suryaprakash Joy M. Thomas N.I. Juvale Sunil Sathe Aziz Khan Sandeep Bansal Viveka Kumar Rajshekhar Reddi
author_sort	Jamshed J. Dalal
title	Therapeutic adherence in hypertension: Current evidence and expert opinion from India
title_short	Therapeutic adherence in hypertension: Current evidence and expert opinion from India
title_full	Therapeutic adherence in hypertension: Current evidence and expert opinion from India
title_fullStr	Therapeutic adherence in hypertension: Current evidence and expert opinion from India
title_full_unstemmed	Therapeutic adherence in hypertension: Current evidence and expert opinion from India
title_sort	therapeutic adherence in hypertension: current evidence and expert opinion from india
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/68c1549d50c9417eabbedcbf7b1ddafd
work_keys_str_mv	AT jamshedjdalal therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT prafullakerkar therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT santanuguha therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT arupdasbiswas therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT jpssawhney therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT sivakadakshamnatarajan therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT srinivasaraomaddury therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT asreenivaskumar therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT nishithchandra therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT gullasuryaprakash therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT joymthomas therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT nijuvale therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT sunilsathe therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT azizkhan therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT sandeepbansal therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT vivekakumar therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia AT rajshekharreddi therapeuticadherenceinhypertensioncurrentevidenceandexpertopinionfromindia
_version_	1718400956726509568

Therapeutic adherence in hypertension: Current evidence and expert opinion from India

Ejemplares similares